e-learning
resources
ERJ
2006
Login
Search all ERS
e-learning
resources
Disease Areas
Airways Diseases
Interstitial Lung Diseases
Respiratory Critical Care
Respiratory Infections
Paediatric Respiratory Diseases
Pulmonary Vascular Diseases
Sleep and Breathing Disorders
Thoracic Oncology
Events
International Congress
Courses
Webinars
Conferences
Research Seminars
Journal Clubs
Publications
Breathe
Monograph
ERJ
ERJ Open Research
ERR
European Lung White Book
Handbook Series
Guidelines
All ERS guidelines
e-learning
CME Online
Case reports
Short Videos
SpirXpert
Procedure Videos
CME tests
Reference Database of Respiratory Sounds
Radiology Image Challenge
Brief tobacco interventions
EU Projects
VALUE-Dx
ERN-LUNG
ECRAID
UNITE4TB
Disease Areas
Events
Publications
Guidelines
e-learning
EU Projects
Login
Search
Circulating haemopoietic and endothelial progenitor cells are decreased in COPD
Palange P., Testa U., Huertas A., Calabro L., Antonucci R., Petrucci E., Pelosi E., Pasquini L., Satta A., Morici G., Vignola M. A., Bonsignore M. R.
Source:
Eur Respir J 2006; 27: 529-541
Journal Issue:
March
Disease area:
Airway diseases
Rating:
You must
login
to grade this presentation.
Share or cite this content
Citations should be made in the following way:
Palange P., Testa U., Huertas A., Calabro L., Antonucci R., Petrucci E., Pelosi E., Pasquini L., Satta A., Morici G., Vignola M. A., Bonsignore M. R.. Circulating haemopoietic and endothelial progenitor cells are decreased in COPD. Eur Respir J 2006; 27: 529-541
You must
login
to share this Presentation/Article on Twitter, Facebook, LinkedIn or by email.
Member's Comments
No comment yet.
You must
Login
to comment this presentation.
Related content which might interest you:
Panel discussion on ERS Statement – A core outcome set for clinical trials evaluating the management of COPD exacerbations
ERS statement: a core outcome set for clinical trials evaluating the management of COPD exacerbations
Evidence-based eHealth for COPD
Related content which might interest you:
Circulating endothelial progenitor cells in COPD: effect of pulmonary hypertension
Source: Annual Congress 2007 - Cellular and molecular aspects of pulmonary hypertension
Year: 2007
Targeting of c-kit+ haematopoietic progenitor cells prevents hypoxic pulmonary hypertension
Source: Eur Respir J 2011; 37: 1392-1399
Year: 2011
Distinct patterns of circulating endothelial cells in pulmonary hypertension
Source: Eur Respir J 2010; 36: 1284-1293
Year: 2010
Circulating endothelial progenitor cells and CD45+ cells in pulmonary arteries of COPD patients
Source: Annual Congress 2010 - Pulmonary circulation II
Year: 2010
Increased levels of circulating endothelial progenitor cells during exacerbations of COPD
Source: Annual Congress 2007 - Biomarkers and assessment of COPD
Year: 2007
Circulating endothelial progenitor cells and chronic pulmonary diseases
Source: Eur Respir J 2011; 37: 426
Year: 2011
Effects of training on endothelial function and circulating endothelial progenitor cells in COPD patients
Source: Annual Congress 2008 - Pulmonary hypertension I
Year: 2008
Low circulating CD34+ cells in chronic obstructive pulmonary disease (COPD)
Source: Eur Respir J 2005; 26: Suppl. 49, 362s
Year: 2005
Endothelial progenitor cells and pulmonary vascular remodeling in chronic obstructive pulmonary disease (COPD)
Source: Eur Respir J 2004; 24: Suppl. 48, 435s
Year: 2004
Endothelial progenitor cells (EPC) in patients with chronic bronchitis or COPD
Source: Annual Congress 2009 - Mechanisms of pulmonary inflammation and fibrosis
Year: 2009
Modulating progenitor accumulation attenuates lung angiogenesis in a mouse model of asthma
Source: Eur Respir J 2011; 38: 679-687
Year: 2011
Endothelial progenitor cells in patients with chronic obstructive pulmonary disease
Source: Annual Congress 2008 - Regulatory mechanisms of cell activation, renewal and recruitment
Year: 2008
Decreased number of circulating endothelial progenitor cells in patients with emphysema
Source: Eur Respir J 2005; 26: Suppl. 49, 441s
Year: 2005
Circulating endothelial progenitor cells in patients with idiopathic pulmonary fibrosis (preliminary results)
Source: Annual Congress 2008 - Management of idiopathic pulmonary fibrosis: what can we learn from the pathophysiology?
Year: 2008
Increased expression of TERT mRNA expresssion in bone marrow-derived mesenchymal stem cells (BM-MSCs) in patients with chronic obstructive pulmonary disease (COPD): Preliminary results
Source: Annual Congress 2010 - Novel mechanisms in COPD
Year: 2010
Increased circulating fibrocytes and their capacity of proliferation and differentiation in clinically unstable patients with chronic obstructive pulmonary disease
Source: Annual Congress 2013 –COPD: new markers of diseases
Year: 2013
Imbalance between circulating endothelial cells and endothelial progenitors in idiopathic pulmonary fibrosis
Source: Annual Congress 2011 - What is new in the approach to pulmonary fibrosis?
Year: 2011
Circulating fibrocytes are increased in children and young adults with pulmonary hypertension
Source: Eur Respir J 2011; 39: 104-111
Year: 2012
Circulating fibrocytes are increased in children and young adults with pulmonary hypertension
Source: Eur Respir J 2012; 39: 104-111
Year: 2012
Treprostinil inhibits the recruitment of bone marrow-derived circulating fibrocytes in chronic hypoxic pulmonary hypertension
Source: Eur Respir J 2010; 36: 1302-1314
Year: 2010
We use cookies on our website to give you the most relevant experience by remembering your preferences and repeat visits. By clicking "Accept", you consent to the use of the cookies.
Accept